Teva Api India Profile
Key Indicators
- Authorised Capital ₹ 1,400.00 Cr
as on 24-10-2024
- Paid Up Capital ₹ 75.98 Cr
as on 24-10-2024
- Company Age 22 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -12.05%
(FY 2023)
- Profit 11.86%
(FY 2023)
- Ebitda 2.01%
(FY 2023)
- Net Worth 2.86%
(FY 2023)
- Total Assets 13.55%
(FY 2023)
About Teva Api India
The Corporate was formerly known as Regent Drugs Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1,400.00 Cr and a paid-up capital of Rs 75.98 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Teva Api India Private Limited India is Komal Mohnani as COMPANY SECRETARY. Muneshvar Singh, Vinay Sharma, and Nishank Bhargava serve as directors at the Company.
- CIN/LLPIN
U74899MH2002PTC326704
- Company No.
326704
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Apr 2002
- Date of AGM
02 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Teva Api India?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Komal Mohnani | Company Secretary | 01-Jun-2022 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vinay Sharma  | Director | 04-Jun-2021 | Current |
| Nishank Bhargava | Director | 24-Feb-2022 | Current |
| Muneshvar Singh | Director | 28-Mar-2020 | Current |
Financial Performance and Corporate Structure Insights of Teva Api India.
Teva Api India Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 12.05% decrease. The company also saw a substantial improvement in profitability, with a 11.86% increase in profit. The company's net worth moved up by a moderate rise of 2.86%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Teva Api India?
In 2023, Teva Api India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Teva Pharmaceutical And Chemical Industries India Private LimitedActive 21 years 7 monthsNishank Bhargava is a mutual person
Actavis Pharma Development Centre Private LimitedActive 18 years 4 monthsNishank Bhargava is a mutual person
Teva Global Business Services Private LimitedActive 20 years 4 monthsNishank Bhargava is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Teva Api India?
Teva Api India has a workforce of 987 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Teva Api India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Teva Api India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
